Close
  Indian J Med Microbiol
 

Figure 1: Noninsulin dose modifications for patients with Type 2 diabetes mellitus. *Sulphonylurea combination therapy OD – take at iftar and consider reducing the dose by 50%; **Sulphonylurea combination therapy BID – omit morning dose and take normal dose at iftar. BID: Twice daily; DPP.4: Dipeptidyl peptidase-4; GLP-1 RAs: Glucagon-like protein-1 receptor agonists; OD: Once daily; SGLT2: Sodium-glucose co.transporter 2; SU: Sulphonylurea; TID: Three times a day; TZD: Thiazolidinedione; T2DM: Type 2 diabetes mellitus. Obtained from Hassanein et al.[2] with permission

Figure 1: Noninsulin dose modifications for patients with Type 2 diabetes mellitus. *Sulphonylurea combination therapy OD – take at iftar and consider reducing the dose by 50%; **Sulphonylurea combination therapy BID – omit morning dose and take normal dose at iftar. BID: Twice daily; DPP.4: Dipeptidyl peptidase-4; GLP-1 RAs: Glucagon-like protein-1 receptor agonists; OD: Once daily; SGLT2: Sodium-glucose co.transporter 2; SU: Sulphonylurea; TID: Three times a day; TZD: Thiazolidinedione; T2DM: Type 2 diabetes mellitus. Obtained from Hassanein <i>et al</i>.<sup>[2]</sup> with permission